创新医疗
(002173)
| 流通市值：70.79亿 | | | 总市值：74.22亿 |
| 流通股本：4.21亿 | | | 总股本：4.41亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 512,473,983.32 | 337,763,261.5 | 166,663,239.83 | 781,251,044.68 |
| 营业收入 | 512,473,983.32 | 337,763,261.5 | 166,663,239.83 | 781,251,044.68 |
| 二、营业总成本 | 597,203,125.52 | 394,716,441.55 | 192,751,923.47 | 852,868,865.07 |
| 营业成本 | 505,759,029.82 | 332,902,222.38 | 162,522,076.05 | 727,278,014.63 |
| 税金及附加 | 9,749,102.9 | 6,876,318.54 | 2,722,266.9 | 10,832,243.03 |
| 销售费用 | 8,394,028.27 | 4,972,994.5 | 3,463,916.8 | 8,216,008.66 |
| 管理费用 | 68,011,486.86 | 46,455,264.53 | 22,289,354.89 | 102,837,760.3 |
| 研发费用 | 5,247,264.46 | 3,471,611.49 | 1,758,051.59 | 3,107,295.68 |
| 财务费用 | 42,213.21 | 38,030.11 | -3,742.76 | 597,542.77 |
| 其中:利息费用 | 1,928,032.07 | 2,059,760.47 | 673,295.44 | 3,815,098.77 |
| 其中:利息收入 | 3,745,972.55 | 2,612,651.7 | 1,324,854.67 | 4,380,488.88 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -151,445.68 | 1,025,434.25 | 511,845.21 | 4,772,921.17 |
| 加:投资收益 | -583,100.88 | 535,968.55 | -1,193,171.19 | 32,155,570.61 |
| 资产处置收益 | 25,803.11 | 25,803.11 | - | 15,644.3 |
| 资产减值损失(新) | - | 0 | -150,357.54 | -1,152,889.59 |
| 信用减值损失(新) | 306,996.11 | 1,695,658.64 | 673,656.39 | 3,956,832.11 |
| 其他收益 | 1,108,649.41 | 266,447.5 | 168,534.3 | 1,300,779.12 |
| 四、营业利润 | -84,022,240.13 | -53,403,868 | -26,078,176.47 | -30,568,962.67 |
| 加:营业外收入 | 799,783.61 | 665,512.38 | 5,438.05 | 15,618,668.86 |
| 减:营业外支出 | 1,508,751.83 | 1,730,973.38 | 414,904.02 | 13,934,375.82 |
| 五、利润总额 | -84,731,208.35 | -54,469,329 | -26,487,642.44 | -28,884,669.63 |
| 减:所得税费用 | -609,429.29 | 228,915.55 | -134,803.72 | 7,370,635.43 |
| 六、净利润 | -84,121,779.06 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -84,121,779.06 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -81,297,789.06 | -52,830,895.3 | -25,149,687.78 | -34,854,476.42 |
| 少数股东损益 | -2,823,990 | -1,867,349.25 | -1,203,150.94 | -1,400,828.64 |
| 扣除非经常损益后的净利润 | -84,416,074.62 | -55,946,948.73 | -25,287,432.04 | -79,028,820.06 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.18 | -0.12 | -0.06 | -0.08 |
| (二)稀释每股收益 | -0.18 | -0.12 | -0.06 | -0.08 |
| 九、综合收益总额 | -84,121,779.06 | -54,698,244.55 | -26,352,838.72 | -36,255,305.06 |
| 归属于母公司股东的综合收益总额 | -81,297,789.06 | -52,830,895.3 | -25,149,687.78 | -34,854,476.42 |
| 归属于少数股东的综合收益总额 | -2,823,990 | -1,867,349.25 | -1,203,150.94 | -1,400,828.64 |
| 公告日期 | 2026-10-23 | 2026-08-15 | 2026-04-30 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |